Gemini Biosciences Ltd.

Start Date End Date Funded Value Relevance

CSV

25 50 100

£615,661

Apr 12 - Nov 16

TAILoR (TelmisArtan and InsuLin Resistance in HIV): A Dose-Ranging Phase II Randomised Open-Labelled Trial of Telmisartan as a Strategy for the Reduction of Insulin Resistance in HIV-Positive Individuals on Combination Antiretroviral Therapy (cART)

MRC award to University of Liverpool

£100,000

Mar 16 - Aug 17

Increasing industry engagement & open innovation in health & life sciences

MRC award to University of Liverpool

£3,072,999

Mar 14 - Dec 22

Centre for Drug Safety Science (CDSS)

MRC award to University of Liverpool and Kevin Park

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}